2013 Press Releases
December 9
QLT Announces First Patient Dosed in Phase IIa Proof-of-Concept Trial for QLT091001 in Impaired Dark Adaptation
PDF Format
November 20
QLT Announces Oral Retinoid Program Clinical and Regulatory Update, and Review of Strategic Alternatives
November 11
QLT Announces Resignation of Vicente Anido, Jr. as Director
November 7
QLT Announces Third Quarter 2013 Results
August 1
QLT Announces Second Quarter 2013 Results
June 27
QLT Announces Completion of US$200 Million Special Cash Distribution to Shareholders
June 14
QLT Announces Shareholder Approval of US$200 Million Special Cash Distribution to Shareholders and Election Results
May 2
QLT Announces 2013 First Quarter Results
April 15
QLT Proposes US$200 Million Special Cash Distribution to Shareholders
April 4
QLT Completes Sale of Punctal Plug Technology to Mati Therapeutics
February 21
QLT Announces Fourth Quarter and Year End 2012 Results
January 28
QLT Board Issues Letter to Shareholders Announcing Corporate Progress and 2013 Objectives
